GlassScriptPhysician profile
Andrew M Bakken
NPI 1376648113
$3,230.77
in general payments reported to CMS, 2019-2025
9 companies · $1,253 in 2025
The $1,253 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $96.88 · 2021: $1,246 · 2022: $151 · 2023: $97.60 · 2024: $154 · 2025: $1,253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,142 · Food and Beverage: $363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,141.83 |
| Food and Beverage | $362.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,307.69 | 2023-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis |
| Silk Road Medical, INC. | $1,035.22 | 2021 | |
| Medtronic, INC. | $305.39 | 2022-2024 | Endurant Iis, Heli-Fx Endoanchor System, In.Pact Admiral |
| Globus Medical, INC. | $178.06 | 2021 | |
| Bard Peripheral Vascular, INC. | $157.12 | 2019 | |
| Medtronic Vascular, INC. | $110.78 | 2019-2020 | |
| Cook Medical LLC | $93.89 | 2020-2021 | |
| Terumo Medical Corporation | $26.91 | 2025 | Navicross, Glidewire |
| Boston Scientific Corporation | $15.71 | 2025 | Enroute Transcarotid Neuroprotection System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Bakken listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.